Explore more publications!

Technology Journal Nepal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal Nepal.

Press releases published on January 7, 2026

JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with  M4 PAM - NTX-253 for Schizophrenia
Synchronoss präsentiert auf der CES2026 seine erweiterte Personal‑Cloud‑Plattform und die Dynamik von Capsyl, verbunden mit einem Ausblick auf neues Angebot
Synchronoss presenta la plataforma Personal Cloud ampliada, el impulso de Capsyl y adelanta una nueva oferta en CES 2026
Synchronoss présente sa plateforme de cloud personnel étendue, la dynamique de Capsyl, et dévoile en avant-première sa nouvelle offre au CES 2026
Synchronoss מציגה את פלטפורמת הענן האישי המורחבת שלה, Capsyl Momentum, ומציגה תצוגה מקדימה של היצע חדש ב-CES 2026
Synchronoss Memamerkan Perluasan Platform Personal Cloud, Momentum Capsyl, dan Menampilkan Pratinjau Penawaran Baru di CES 2026
シンクロノス、拡大したパーソナルクラウドプラットフォーム、Capsylの勢いを披露し、CES 2026で新サービスをプレビュー
Synchronoss, CES 2026에서 확장된 퍼스널 클라우드 플랫폼과 Capsyl 성장 모멘텀 공개…신규 서비스도 예고
Synchronoss Pamerkan Platform Personal Cloud yang Dipertingkatkan, Momentum Capsyl serta Pratonton Tawaran Baharu di CES 2026
Synchronoss จัดแสดงแพลตฟอร์มคลาวด์ส่วนบุคคลที่ได้รับการพัฒนาต่อยอดให้ดียิ่งขึ้นและแรงเหวี่ยงจาก Capsyl และนำเสนอตัวอย่างผลิตภัณฑ์ใหม่ในงาน CES 202…
Synchronoss Apresenta Plataforma de Nuvem Pessoal Expandida, Momento da Capsyl e Nova Oferta na CES 2026
Synchronoss 在 2026 消費電子展上呈現其擴充的個人雲端平台、Capsyl 強勁發展,並預覽全新服務
Synchronoss 在 CES 2026 展示扩展个人云平台、强调 Capsyl 发展势头并发布全新产品预览
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288
HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
GDU Launches UAV-P300, The World’s First Drone with AI-Driven Optical & Electronic Fog Penetration Capabilities

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions